Deerfield Beach, FL -- (SBWIRE) -- 11/18/2016 -- How Big is the Global Urinary Tract Infection Treatment Market?

The global urinary tract infection treatment market is expected to exceed more than US$ 10 Billion by 2022; Growing at a CAGR of more than 2% in the given forecast period.

Download Free Sample Report: https://www.marketresearchengine.com/requestsample/urinary-tract-infection-treatment-market

Urinary tract infection (UTI) arises in the kidneys, ureter, urethra and bladder because of microbial pathogens in these parts. Urinary tract infections will be uncomplicated or complicated depends on the severity of infection. The penicillin antibiotic that is amoxicillin is used to treat urinary tract infections and it is mainly used as prescribed antibiotic for uncomplicated urinary tract infection. UTI is common bacterial infections affecting many of peoples globally. Continuing urinary tract infection is a main health problem in females worldwide. Patients with spinal cord injury or urinary catheter are mainly contract complicated urinary tract infections.

The urinary tract infection treatment market is segmented on the lines of its drug type, indication, distribution channel and regional. Based on drug type segmentation it covers sulphonamides, azoles and amphotericin B, tetracycline, nitrofurans, aminoglycoside antibiotics, cephalosporin, quinolones and penicillin & combinations. Aminoglycoside antibiotics is further segmented into amikacin and gentamicin. Cephalosporin segmentation covers ceftriaxone, cefuroxime, cefixime and cephalexin. Under quinolones segmentation it covers ciprofloxacin, levofloxacin, nalidixic acid, norfloxacin and others. Penicillin and combinations covers amoxicillin, amoxicillin & clavulanate potassium and others.

The urinary tract infection treatment market is segmented on the lines of its indication like into complicated UTI, recurring complicated UTI, uncomplicated UTI and neurogenic bladder infections. Under distribution channel segmentation it covers hospital pharmacies, gynaecology and urology clinics, drug store, retail pharmacies and online drug stores. The urinary tract infection treatment market's geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for urinary tract infection treatment and related technologies.

2) Analysis of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.

3) Identifications of new market opportunities and targeted promotional plans for urinary tract infection treatment.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/urinary-tract-infection-treatment-market

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for Urinary Tract Infection Treatment Market for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Johnson and Johnsons Private Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., Bayer AG, GlaxoSmithKline Pharmaceuticals Ltd., Pfizer Inc., F.Hoffmann-La Roche Ltd., Novartis AG. and AstraZeneca plc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry's most influential players.

The Urinary Tract Infection Treatment Market has been segmented as below:

By Drug Type Analysis

Sulphonamides
Azoles and Amphotericin B
Tetracycline
Nitrofurans
Aminoglycoside antibiotics
Amikacin
Gentamicin

Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin

Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others

Penicillin & Combinations
Amoxicillin
Amoxicillin & Clavulanate Potassium
Others

By Indication Analysis

Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections

By Distribution channel Analysis

Hospital Pharmacies
Gynaecology and Urology Clinics
Drug Store
Retail Pharmacies
Online Drug Stores

By Regional Analysis

North America
Europe
Asia-Pacific
Rest of the World

Reasons to Buy this Report:

1) Obtain the most up to date information available on all urinary tract infection treatment .

2) Identify growth segments and opportunities in the industry.

3) Facilitate decision making on the basis of strong historic and forecast of urinary tract infection treatment data.

4) Assess your competitor's refining portfolio and its evolution.

About Market Research Engine
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.